Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

26.09
+0.04000.15%
Post-market: 26.01-0.0800-0.31%19:30 EDT
Volume:321.12K
Turnover:8.37M
Market Cap:1.55B
PE:-10.86
High:26.42
Open:25.99
Low:25.18
Close:26.05
52wk High:40.65
52wk Low:11.70
Shares:59.49M
Float Shares:35.21M
Volume Ratio:0.78
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4031
EPS(LYR):-2.0125
ROE:-45.31%
ROA:-28.46%
PB:4.39
PE(LYR):-12.96

Loading ...

Tyra Biosciences reports Q1 EPS (64c), consensus (59c)

TIPRANKS
·
May 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA)

TIPRANKS
·
May 13

Earnings Flash (TYRA) Tyra Biosciences Posts Q1 Net Loss $0.64 a Share, vs. FactSet Est of $0.59 Loss

MT Newswires Live
·
May 13

Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate

Benzinga Earnings
·
May 13

Tyra Biosciences Q1 FY26 net loss widens to $39.31 million

Reuters
·
May 13

Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

THOMSON REUTERS
·
May 13

Tyra Biosciences Inc: Cash, Cash Equivalents and Marketable Securities of $383.5 Mln at Q1 2026; Runway Into 2H 2028

THOMSON REUTERS
·
May 13

Tyra Biosciences Q1 EPS USD -0.64

THOMSON REUTERS
·
May 13

Tyra Biosciences Q1 Operating Expenses USD 41.998 Million

THOMSON REUTERS
·
May 13

Tyra Biosciences to present at BofA Securities Health Care Conference

Reuters
·
May 08

How TYRA-300 Bladder Cancer Data and New Trial Partnership Will Impact Tyra Biosciences (TYRA) Investors

Simply Wall St.
·
May 06

Does Tyra Biosciences (TYRA) Board Refresh and Dabogratinib Spotlight Reframe Its Pipeline Credibility?

Simply Wall St.
·
Apr 27

Tyra Biosciences director Habib J. Dable files initial beneficial ownership statement

Reuters
·
Apr 21

Tyra Biosciences announces annual shareholder meeting via webcast

Reuters
·
Apr 17

Tyra Biosciences appoints Habib Dable to board of directors

Reuters
·
Apr 17

Tyra Biosciences Announces Appointment of Habib Dable to Its Board of Directors

THOMSON REUTERS
·
Apr 17

Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch

TIPRANKS
·
Apr 17

This Tyra Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Benzinga
·
Apr 15

Guggenheim Initiates Tyra Bioscience at Buy With $54 Price Target

MT Newswires Live
·
Apr 15

Tyra Biosciences Initiated at Buy by Guggenheim

Dow Jones
·
Apr 15